Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingested Interferon Alpha for Cognitive Decline in Alzheimer's Disease
NCT00031018Phase 2Unknown
- Sponsor
- National Center for Research Resources
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2a in Alzheimer's disease (AD), sponsored by National Center for Research Resources. Status: unknown.
02
Drugs
interferon alfa-2a
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00031018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031018.